Article Details

Fortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel Anti-CD46 ...

Retrieved on: 2018-11-05 22:37:30

Tags for this article:

Click the tags to see associated articles and topics

Fortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel Anti-CD46 .... View article details on hiswai:

Excerpt

<div>... Bin Liu, Ph.D. The company's investors are <b>Avalon Ventures</b>, Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up